Skip to main content
Equibles

Andrew Oakley

Onconetix, Inc. (ONCO)

Board Member

Onconetix, Inc. (ONCO)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Andrew Oakley

Andrew Oakley is recorded as Board Member at Onconetix, Inc. (ONCO). Onconetix, Inc. reported in an 8-K filed April 24, 2026 that Andrew Oakley resigned as Board of Directors, effective April 20, 2026. Onconetix, Inc. reported in an 8-K filed April 24, 2026 that Andrew Oakley resigned as Chairman of the Board, effective April 20, 2026. Onconetix, Inc. reported in an 8-K filed July 16, 2025 that Andrew Oakley was appointed Lead Independent Director, effective July 12, 2025. Equibles holds 4 filed executive changes naming Andrew Oakley; each is listed under recent activity with its source filing.

“Andrew Oakley and Thomas Meier notified the Board of Directors (the "Board") of Onconetix, Inc, a Delaware corporation (the "Company"), of their resignation from the Board.”
Onconetix, Inc. Form 8-K, filed April 24, 2026 · Read the filing
“Mr. Oakley has also resigned from his position as Chairman of the Board and his service on the Audit Committee, Compensation Committee and the Nominating and Corporate Governance Committee”
Onconetix, Inc. Form 8-K, filed April 24, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Onconetix, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.